)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals (CYCC) investor relations material
Cyclacel Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Shifted focus from biopharmaceuticals to fire safety protection and distribution after acquiring Fitters Sdn. Bhd. in Malaysia on September 12, 2025.
Deconsolidated UK subsidiary Cyclacel Limited after its liquidation in January 2025, resulting in a $5.0 million gain.
Sold remaining biopharmaceutical asset, plogosertib, in October 2025 for $300,000 plus a potential $170,000 milestone payment.
Implemented a one-for-fifteen reverse stock split in July 2025 to meet Nasdaq requirements.
Entered into multiple warrant exchange agreements, issuing new shares in exchange for existing warrants.
Financial highlights
Net loss for the nine months ended September 30, 2025, was $2.4 million, a significant improvement from $8.2 million loss in the same period last year.
Cash and cash equivalents stood at $3.8 million as of September 30, 2025.
Product revenue from fire safety equipment sales was $81,000 for Q3 2025.
Cost of sales for fire safety equipment was $64,000 for Q3 2025.
General and administrative expenses increased to $6.5 million, up 46% year-over-year due to one-time costs from changes in control.
Outlook and guidance
Anticipates revenue growth in Q4 2025 following full integration of Fitters Sdn. Bhd.
No further material research and development expenditures expected after divestiture of biopharma assets.
Substantial doubt exists about ability to continue as a going concern beyond Q1 2026 without additional funding.
Current cash resources are expected to fund planned expenditures into Q1 2026.
Fire safety segment gross margin?
Cash runway extension strategy?
Rationale for Plogosertib asset sale?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cyclacel Pharmaceuticals
- Lower Q2 loss and R&D spend, but cash runway and compliance risks persist.CYCC
Q2 20241 Feb 2026 - FADRA demonstrates durable responses in biomarker-driven cancer trials; PLOGO reformulation underway.CYCCH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Stockholders will vote on key proposals that could shift control and restructure the company's capital.CYCCProxy Filing2 Dec 2025
- Shareholders to vote on equity issuances, reverse split, and governance changes to secure funding.CYCCProxy Filing2 Dec 2025
- Shareholders to vote on equity issuances, reverse split, and governance changes to ensure compliance.CYCCProxy Filing2 Dec 2025
- Virtual annual meeting to vote on directors, equity plan amendment, and executive pay.CYCCProxy Filing2 Dec 2025
- Virtual meeting to vote on director elections, equity plan amendment, and executive pay.CYCCProxy Filing2 Dec 2025
- Key votes include share issuance, corporate name change, and governance amendments.CYCCProxy Filing2 Dec 2025
- Biopharma pivots to single cancer drug, acquires Fitters, faces urgent funding and integration risks.CYCCRegistration Filing29 Nov 2025
- Focused on a single cancer drug, the company faces urgent funding needs and high dilution risk.CYCCRegistration Filing29 Nov 2025
Next Cyclacel Pharmaceuticals earnings date
Q4 202520 Mar, 2026
Cyclacel Pharmaceuticals
Next Cyclacel Pharmaceuticals earnings date
Q4 202520 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies. The company's research and development efforts target the regulation of the cell cycle, aiming to treat cancers and other serious diseases that result from abnormal cell division. Cyclacel's pipeline includes small-molecule drugs designed to inhibit specific enzymes and proteins involved in cancer cell growth and survival. The company's therapeutic candidates are being developed for a range of oncology applications, with the goal of addressing unmet medical needs in cancer treatment. The company is headquartered in Berkeley Heights, New Jersey, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage